Electrocore LLC (ECOR) is a Healthcare · Medical Devices company listed on NASDAQ. Price $11.68 (+2.64%), Market cap $0.05B, 52-week low–high $4.31 ~ $8.15.
electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga 350, a personal use consumer electronics general wellness product and Truvaga Plus, an app-enabled general wellness product. It also offers non-invasive bioelectronic therapies f
Financial statements, price targets, institutional (13F) holdings and related news for Electrocore LLC are updated in real time on BlackAll Trade.
Electrocore LLC trades at $11.68 (+2.64%). Real-time quotes and charts are available on BlackAll Trade.
Electrocore LLC has a market cap of about $0.05B.
electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom,